Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Cited by (1,004)

Items 601–700 of 1,004

1. Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks
   Rupinder Mann, Abhilash Perisetti, Mahesh Gajendran, Zainab Gandhi, Chandraprakash Umapathy, Hemant Goyal · 2020 · Frontiers in Medicine
2. Role of fever and ambient temperature in COVID-19
   Muhammad Hamdan Gul, Zin Mar Htun, Asad Inayat · 2020 · Expert Review of Respiratory Medicine
3. Initial Report From a Swedish High-Volume Transplant Center After The First Wave of The COVID-19 Pandemic.
   M. Felldin, J. M. Søfteland, J. Magnusson · 2020 · Transplantation
4. Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
   Samir Awasthi, Tyler Wagner, AJ Venkatakrishnan, Arjun Puranik, Matthew Hurchik, Vineet Agarwal, Ian Conrad, Christian Kirkup, Raman Arunachalam, John Charles O’Horo et al. · 2021 · Cell Death Discovery
5. Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review
   Jyoti Mehta, Rajan Rolta, Brij Bhushan Mehta, Neha Kaushik, Eun Ha Choi, Nagendra Kumar Kaushik · 2022 · Frontiers in Microbiology
6. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
   Evgeny Lvovich Nasonov, Aleksander M. Lila, Mazurov Vi, Boris Sergeyevich Belov, Andrey E. Karateev, Т. В. Дубинина, O. A. Nikitinskaya, Andrey A. Baranov, Diana Ildarovna Abdulganieva, Sergey Valentinovich Moiseev et al. · 2021 · Rheumatology Science and Practice
7. Impact of COVID‐19 in Liver Disease Progression
   Miguel Ángel Martı́nez, Sandra Franco · 2021 · Hepatology Communications
8. Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial
   Jose Lenin Beltran Gonzalez, Mario González Gámez, Emanuel Antonio Mendoza Enciso, Ramiro Josue Esparza Maldonado, Daniel Hernández Palacios, Samuel Dueñas Campos, Itzel Ovalle Robles, Mariana Jocelyn Macías Guzmán, Andrea Lucia García Díaz, César Mauricio Gutiérrez Peña et al. · 2022 · Infectious Disease Reports
9. Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
   Carolina García‐Vidal, Alberto Cózar-Llistó, Fernanda Salazar Meira, Gerard Dueñas, Pedro Puerta‐Alcalde, Catia Cillóniz, Nicole García-Pouton, Mariana Chumbita, Celia Cardozo, Marta Hernández et al. · 2021 · The Lancet Regional Health - Europe
10. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection
    Zi‐Wei Ye, Shuofeng Yuan, Jasper Fuk‐Woo Chan, Jinxia Zhang, Ching-Yun Yu, Chon Phin Ong, Dong Yang, Chris Chun-Yiu Chan, Kaiming Tang, Jianli Cao et al. · 2021 · Emerging Microbes & Infections
11. Current evidence for COVID-19 therapies: a systematic literature review
    Tobias Welte, Lucy Ambrose, Gillian C. Sibbring, Shehla Sheikh, Hana Müllerová, Ian N. Sabir · 2021 · European Respiratory Review
12. Targeting progesterone signaling prevents metastatic ovarian cancer
    Olga Kim, Eun Young Park, Sun Young Kwon, So‐Jin Shin, Robert E. Emerson, Yong-Hyun Shin, Francesco John DeMayo, John P. Lydon, Donna M. Coffey, Shannon M. Hawkins et al. · 2020 · Proceedings of the National Academy of Sciences
13. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19
    Hsin-Hsien Li, Chen-Chi Liu, Tien-Wei Hsu, Jiun-Han Lin, Jyuan‐Wei Hsu, Anna Fen–Yau Li, Yi‐Chen Yeh, Shih‐Chieh Hung, Han‐Shui Hsu · 2021 · Particle and Fibre Toxicology
14. Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper
    Ludger Klimek, Marek Jutel, Jean Bousquet, Ioana Octavia Agache, Cezmi A. Akdiş, Valérie Hox, Philippe Gevaert, Peter Valentin Tomazic, Carmen Rondón, Cemal Cingi et al. · 2020 · Allergy
15. Cyclosporine and COVID-19: Risk or favorable?
    Nadia Nicholine Poulsen, Albrecht von Brunn, Mads Hornum, Martin Blomberg Jensen · 2020 · American Journal of Transplantation
16. Effects of delayed versus immediate umbilical cord clamping in reducing death or major disability at 2 years corrected age among very preterm infants (APTS): a multicentre, randomised clinical trial
    Kristy Pamela Robledo, William Odita Tarnow-Mordi, Ingrid Rieger, Preeti Suresh, Andrew James Martin, Carbo Yeung, Alpana Ghadge, Helen G. Liley, David Andrew Osborn, Jonathan M Morris et al. · 2021 · The Lancet Child & Adolescent Health
17. Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses
    Matthew A Schaller, Yamini Sharma, Zadia Dupee, Duy Nguyen, Juan Manuel Urueña, Ryan A. Smolchek, Julia C. Loeb, Tiago Machuca, John A. Lednicky, David J. Odde et al. · 2021 · JCI Insight
18. Efficacy and safety of azithromycin in Covid‐19 patients: A systematic review and meta‐analysis of randomized clinical trials
    Ahmed Mohamed Kamel, Mona S. Abdel Monem, Nour A. Sharaf, Nada Magdy, Samar Farghali Farid · 2021 · Reviews in Medical Virology
19. Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID ‐19 research papers
    Amandeep Khatter, Michael Naughton, Hajira Dambha‐Miller, Patrick Redmond · 2021 · Learned Publishing
20. A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results
    Inah Maria Drummond Pecly, Rafael Bellotti Azevedo, Elizabeth Silaid Muxfeldt, Bruna Gopp Botelho, Gabriela Girão de Albuquerque, Pedro Henrique P. Diniz, Rodrigo Silva, Cibele Isaac Saad Rodrigues · 2021 · Brazilian Journal of Nephrology
21. Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions
    Atish Gheware, Dhwani Dholakia, Sadasivam Kannan, Lipsa Rani Panda, Ritu Rani, BIJAY RANJAN PATTNAIK, Vaibhav Jain, Yash Parekh, Mohammed Ghalib Enayathullah, Kiran Kumar Bokara et al. · 2021 · Respiratory Research
22. COVID-19 cytokine storm: targeting the appropriate cytokine
    Randy Quentin Cron · 2021 · The Lancet Rheumatology
23. BridgeDPI: A Novel Graph Neural Network for Predicting Drug-Protein Interactions
    Yifan Wu, Min Gao, Min Zeng · 2021 · arXiv (Cornell University)
24. Early mortality benefit with COVID‐19 convalescent plasma: a matched control study
    Aarthi G. Shenoy, Aaron Zachary Hettinger, Stephen J. Fernandez, Joseph Blumenthal, Valentina Báez · 2021 · British Journal of Haematology
25. Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact
    Sifan Zhang, Becca Asquith, Richard Szydlo, John S. Tregoning, Katrina M. Pollock · 2021 · Immunotherapy Advances
26. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It
    Stefano Cappanera, Michele Palumbo, Sherman H. Kwan, Giulia Priante, Lucia Assunta Martella, Lavinia Maria Saraca, Francesco Sicari, Carlo Vernelli, Cinzia Di Giuli, P. Andreani et al. · 2021 · Journal of Clinical Medicine
27. Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective
    Dominic L. Sykes, Shoaib Faruqi, Luke Holdsworth, Michael George Crooks · 2020 · ERJ Open Research
28. Convalescent plasma may be a possible treatment for COVID-19: A systematic review
    Ying Wang, Pengfei Huo, Rulin Dai · 2020 · International Immunopharmacology
29. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2
    Morag J. Young, Colin D. Clyne, Karen E. Chapman · 2020 · Journal of Endocrinology
30. Retrospective cohort study of admission timing and mortality following COVID-19 infection in England
    Ahmed M. Alaa, Zhaozhi Qian, Jem Rashbass, Jonathan Richard Benger, Mihaela van der Schaar · 2020 · BMJ Open
31. Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce
    Joshua Peter Vogel, Britta Tendal, Michelle Giles, Clare L. Whitehead, Wendy Burton, Samantha Paubrey Chakraborty, Saskia Cheyne, Teena Downton, David Fraile Navarro, Glenda Gleeson et al. · 2020 · Australian and New Zealand Journal of Obstetrics and Gynaecology
32. Autophagy Inhibits Grass Carp Reovirus (GCRV) Replication and Protects Ctenopharyngodon idella Kidney (CIK) Cells from Excessive Inflammatory Responses after GCRV Infection
    Pengfei Chu, Libo He, Rong Huang, Lanjie Liao, Yongming Li, Zuoyan Zhu, Wei Hu, Yaping Wang · 2020 · Biomolecules
33. Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19
    Mohammed M. Alvi, Sowmya Sivasankaran, Mahima Singh · 2020 · Journal of drug targeting
34. Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation
    Paige M Mortimer, Stacey McIntyre, David Thomas · 2021 · Frontiers in Immunology
35. Coronavirus Disease 2019 in Children
    Melissa Borrelli, Adele Corcione, Fabio Castellano, Francesca Fiori Nastro, Francesca Santamaria · 2021 · Frontiers in Pediatrics
36. HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients
    Álvaro Tamayo-Velasco, Pedro Martínez-Paz, María Jesús Peñarrubia-Ponce, Ignacio de la Fuente, Sonia Pérez González, Itziar Fernández, Carlos Dueñas, Esther Gómez‐Sánchez, Mario Lorenzo‐López, Estefanía Gómez‐Pesquera et al. · 2021 · Journal of Clinical Medicine
37. IL-6 modulation for COVID-19: the right patients at the right time?
    Paolo A. Ascierto, Binqing Fu, Haiming Wei · 2021 · Journal for ImmunoTherapy of Cancer
38. Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020
    Alexandra K. Heaney, Jennifer R. Head, Kelly Broen, Karen Click, John William Taylor, John Randolph Balmes, Jon Zelner, Justin V. Remais · 2021 · Emerging infectious diseases
39. Predicting the outcome of COVID-19 infection in kidney transplant recipients
    Özgür Akın Oto, Savaş Öztürk, Kenan Turgutalp, Mustafa Arıcı, Nadir Alpay, Özgür Merhametsiz, Savaş Sipahi, Melike Betül Öğütmen, Berna Yelken, Mehmet Rıza Altıparmak et al. · 2021 · BMC Nephrology
40. Zinc supplementation as an adjunct therapy for COVID‐19: Challenges and opportunities
    Vidyasagar Chinni, Hanna J El-Khoury, Marlon Perera, Rinaldo Bellomo, Daryl A Jones, Damien Michael Bolton, Joseph J. Ischia, Oneel Patel · 2021 · British Journal of Clinical Pharmacology
41. Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa
    Waasila Jassat, Caroline Mudara, Lovelyn Ozougwu, Stefano Tempia, Lucille Hellen Blumberg, Mary‐Ann Davies, Yogan G. Pillay, T Carter, Ramphelane Morewane, Milani Wolmarans et al. · 2021 · medRxiv
42. Time course of endothelial dysfunction markers and mortality in COVID‐19 patients: A pilot study
    Francesco Vieceli Dalla Sega, F. Fortini, S. Spadaro et al. · 2021 · Clinical and Translational Medicine
43. Efficacy of synthetic glucocorticoids in COVID-19 endothelites
    Francesco Ferrara, Antonio Vitiello · 2021 · Naunyn-Schmiedeberg s Archives of Pharmacology
44. Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan
    Samreen Sarfaraz, Quratulain Shaikh, Syed Ghazanfar Saleem, Anum Rahim, Fivzia Farooq Herekar, Samina Junejo, Aneela N. Hussain · 2021 · PLoS ONE
45. COVID-19 in Chronic Liver Disease and Liver Transplantation
    Abdul Mohammed, Neethi Paranji, Po‐Hung Chen, Bolin Niu · 2020 · Journal of Clinical Gastroenterology
46. An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients
    Vinay V Nair, Nicholas Jandovitz, Jamie S. Hirsch, Mersema T. Abate, Sanjaya Kumar Satapathy, Nitzan C. Roth, Santiago J. Miyara, Sara Guevara, Adam M. Kressel, Alec Xiang et al. · 2020 · American Journal of Transplantation
47. Effects of da pagliflozin on prevention of major clinical events and recovery in patients with re spiratory failure because of COVID‐ 19 : Design and rationale for the DARE‐19 study
    Mikhail Kosiborod, Otavio B Berwanger, Gary G. Koch, Felipe A. Martínez, Omar Mukhtar, Subodh Verma, Vijay Chopra, Ali Javaheri, Phil Ambery, Samvel B. Gasparyan et al. · 2020 · Diabetes Obesity and Metabolism
48. Residual Lung Injury in Patients Recovering From COVID ‐19 Critical Illness
    Abdulrahman Mishaal Alharthy, Mohamed Abuhamdah, Abdullah Balhamar, Fahad Ali Faqihi, Nasir Nasim, Shahzad Ahmad, Alfateh Sayed Nasr Noor, Hani Tamim, Saleh A. Alqahtani, Ahad Alhassan Al Saud et al. · 2020 · Journal of Ultrasound in Medicine
49. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis
    Chaomin Wu, Dongni Hou, Chunling Du, Yanping Cai, Junhua Zheng, Jie Xu, Xiaoyan Chen, Cuicui Chen, Xianglin Hu, Yuye Zhang et al. · 2020 · Critical Care
50. COVID-19 in pregnancy and the puerperium: A review for emergency physicians
    Marina N. Boushra, Alex Koyfman, Brit Long · 2020 · The American Journal of Emergency Medicine
51. COVID-19 and the kidney
    Mohamed Hassanein, Yeshwanter Radhakrishnan, John R. Sedor, Tushar J. Vachharajani, Vidula Vachharajani, Joshua J. Augustine, Sevag G. Demirjian, George Thomas · 2020 · Cleveland Clinic Journal of Medicine
52. Pathways to Severe COVID‐19 for People with Obesity
    O’Rourke, Robert W., Lumeng, Carey N. · 2021 · Obesity
53. A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
    Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya et al. · 2022 · Nature Communications
54. Remdesivir and Mortality in Patients With Coronavirus Disease 2019
    G. Diaz, A. Christensen, Tobias Pusch et al. · 2021 · Clinical Infectious Diseases
55. The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients
    Lindsay A. Ritter, Noel Britton, Emily L. Heil, William Arthur Teeter, Sarah B. Murthi, Jonathan H. Chow, Emily Ricotta, Daniel S. Chertow, Alison Grazioli, Andrea R. Levine · 2021 · Journal of Intensive Care Medicine
56. Pericarditis in patients with COVID-19: a systematic review
    C. Díaz-Arocutipa, José Saucedo-Chinchay, M. Imazio · 2021 · Journal of Cardiovascular Medicine
57. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials
    R. Raju, P. V., Pratheeksha Sojan Biatris · 2021 · Future Journal of Pharmaceutical Sciences
58. Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
    Daniele Pala, Marco Pistis · 2021 · Frontiers in Pharmacology
59. Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic
    Bernardo Alfonso Martínez-Guerra, María Fernanda González-Lara, Nereyda A. de-León-Cividanes, Karla Maria Tamez-Torres, Carla Marina Román-Montes, Sandra Rajme‐López, G. Ivonne Villalobos-Zapata, Norma Irene López-García, Areli Martínez‐Gamboa, José Sifuentes‐Osornio et al. · 2021 · Antibiotics
60. COVID-19: Short and Long-Term Effects of Hospitalization on Muscular Weakness in the Elderly
    Lucía Sagarra‐Romero, Andrea Viñas · 2020 · International Journal of Environmental Research and Public Health
61. Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department
    W. Bauer, E. Diehl-Wiesenecker, J. Ulke · 2020 · Journal of Infection
62. Correlating arterial blood gas, acid–base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients
    Morné C Bezuidenhout, Owen J Wiese, Desiree L. Moodley, Elizna Maasdorp, Mogamat Razeen Davids, Coenraad F.N. Koegelenberg, Usha Lalla, Aye Aye Khine Wamono, Annalise E. Zemlin, Brian Allwood · 2020 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
63. Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
    Pataje G.S. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey Craig Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia Chiara Formenti, Chandan Guha, Dale J. Hu et al. · 2020 · Radiation Research
64. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China
    Jianfeng Wu, Jianqiang Huang, Guochao Zhu, Yihao Liu, Han Xiao, Qian Zhou, Hui Yi, Hui Yi, Da-Ya David Yang, 杨大雅 et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
65. What we have to know about corticosteroids use during Sars-Cov-2 infection
    Francesco Ferraù, Filippo Ceccato, Salvatore Cannavò, Carla Maria Scaroni · 2020 · Journal of Endocrinological Investigation
66. Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments
    Robert M. Califf, Adrian F. Hernandez, Martin Landray · 2020 · JAMA
67. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
    Vincenzo Spagnuolo, Monica Guffanti, Laura Galli, Andrea Poli, Patrizia Querini Rovere, Marco Ripa, Massimo Clementi, Paolo Scarpellini, Adriano Lazzarin, Moreno Tresoldi et al. · 2020 · Scientific Reports
68. Review of the COVID-19 Risk in Multiple Sclerosis
    Farhan Chaudhry, Cristina Jageka, Phillip David Levy, Mirela Cerghet, Robert P. Lisak · 2021 · Journal of Cellular Immunology
69. Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling
    Nicholas F. Brazeau, Robert Verity, Sara J. Jenks, Han Jing Fu, Charles Whittaker, Peter Winskill, Ilaria Dorigatti, Patrick G. T. Walker, Steven Riley, Ricardo Parolin Schnekenberg et al. · 2022 · Communications Medicine
70. Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients
    Jonathan Youngs, Nicholas M. Provine, Nicholas T. Y. Lim, Hannah Sharpe, Ali Amini, Yi‐Ling Chen, Jian Fei Luo, Matthew D. Edmans, Panagiota Zacharopoulou, Wentao Chen et al. · 2021 · PLoS Pathogens
71. Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease
    Svetlana Mastitskaya, Nicole Thompson, David S. Holder · 2021 · Frontiers in Neuroscience
72. Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
    Petra Langerbeins, Barbara F. Eichhorst · 2021 · Acta Haematologica
73. COVID-19 and rheumatoid arthritis
    Kristin M. D'Silva, Zachary Scott Wallace · 2021 · Current Opinion in Rheumatology
74. Vestibular Neuritis as Clinical Presentation of COVID-19
    Quentin Mat, Antoine Noël, Lindsay Loiselet, Sophie Tainmont, Carlos Miguel Chiesa-Estomba, Jerome Rene Lechien, Jean‐Pierre Duterme · 2021 · Ear Nose & Throat Journal
75. Evaluation of patient characteristics, management and outcomes for COVID-19 at district hospitals in the Western Cape, South Africa: descriptive observational study
    Robert James Mash, Mellisa Presence-Vollenhoven, Adeloye A. Adeniji, Renaldo Christoffels, Karlien Doubell, Lawson Eksteen, Amee Hendrikse, Lauren Hutton, Louis Stander Jenkins, Paul Kapp et al. · 2021 · BMJ Open
76. COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations
    Bin Zhou, Shinsuke Kojima, Atsuhiko Kawamoto, Masanori Fukushima · 2020 · Journal of Medical Virology
77. Cyclosporine A plus low‐dose steroid treatment in COVID‐19 improves clinical outcomes in patients with moderate to severe disease: A pilot study
    José Luis Gálvez-Romero, Oscar Palmeros-Rojas, F. A. Real‐Ramírez, Silvia Sánchez-Romero, R. Tome‐Maxil, María de Lourdes Patricia Ramírez-Sandoval, R. Olivos‐Rodríguez, S. E. Flores‐Encarnación, A. A. Cabrera‐Estrada, J. Ávila‐Morales et al. · 2020 · Journal of Internal Medicine
78. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
    Murat Öz, Dietrich Ernst Lorke, Nadine Kabbani · 2020 · Pharmacology & Therapeutics
79. Harnessing the Neural Stem Cell Secretome for Regenerative Neuroimmunology
    Cory M. Willis, Alexandra M. Nicaise, Regan Hamel, Vasiliki Pappa, Luca Peruzzotti‐Jametti, Stefano Pluchino · 2020 · Frontiers in Cellular Neuroscience
80. Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
    Jae Chol Choi, Sun‐Young Jung, Una Amelia Yoon, Seung‐Hun You, Myo-Song Kim, Moon Seong Baek, Jae‐Woo Jung, Won‐Young Kim · 2020 · Journal of Clinical Medicine
81. Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients
    Yazdan Yazdanpanah, French COVID cohort investigators and study group · 2020 · Journal of Medical Virology
82. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
    C. Mason, Tanmay Kanitkar, C. Richardson et al. · 2020 · Journal of Antimicrobial Chemotherapy
83. CAR Macrophages for SARS-CoV-2 Immunotherapy
    Wenyan Fu, Changhai Lei, Kewen Qian, Zetong Ma, Li Tian, Fangxin Lin, Wei Zhang, Jian Zhao, Shi Hu · 2021 · Frontiers in Immunology
84. Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review
    Zeraatkar, Dena, Pitre, Tyler, Leung, Gareth, Cusano, Ellen, Agarwal, Arnav, Khalid, Faran, Escamilla, Zaira, Cooper, Matthew Adam, Ghadimi, Maryam, Wang, Ying et al. · 2022 · BMJ Medicine
85. A Review of the Evidence for Corticosteroids in COVID-19
    Meagan L. Johns, Stephy George, Margarita Taburyanskaya, Yi Kee Poon · 2021 · Journal of Pharmacy Practice
86. Nowcasting epidemics of novel pathogens: lessons from COVID-19
    Joseph Tsz Kei Wu, Kathy S. M. Leung, Tommy Tsan‐Yuk Lam, Michael Yuxuan Ni, Carlos King Ho Wong, Malik J. S. Peiris, Gabriel Matthew Leung · 2021 · Nature Medicine
87. A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms
    Mohammad Amin Langarizadeh, Marziye Ranjbar Tavakoli, Ardavan Abiri, Ali Ghasempour, Masoud Rezaei, Alieh Ameri · 2020 · EXCLI journal
88. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer
    Erin Bange, N. Han, Paul Wileyto et al. · 2021 · Research Square
89. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
    Barbara Malinowska, Marta Baranowska‐Kuczko, Aleksandra Kicman, Eberhard Schlicker · 2021 · International Journal of Molecular Sciences
90. Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
    Evangelos Terpos, Marianna Politou, Theodoros Ν. Sergentanis, Andreas F. Mentis, Margherita Rosati, Dimitris Stellas, Jenifer Bear, Xintao Hu, Barbara K. Felber, Vasiliki Pappa et al. · 2020 · Microorganisms
91. Does inpatient hyperglycemia predict a worse outcome in COVID‐19 intensive care unit patients?
    Aisha Rasool Saand, Monica Flores, Tariq Zuheir Kewan, Sura Alqaisi, Mahmoud I Alwakeel, Lori A. Griffiths, Xiaofeng Wang, Xiaozhen Han, Robert Burton, Mohammed Al‐Jaghbeer et al. · 2020 · Journal of Diabetes
92. Risk Factors for Invasive Pulmonary Aspergillosis in Critically Ill Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome
    P. Chauvet, J. Mallat, Clothilde Arumadura · 2020 · Critical Care Explorations
93. Repurposing existing drugs for COVID-19: an endocrinology perspective
    Flavio Cadegiani · 2020 · BMC Endocrine Disorders
94. Endocrine involvement in COVID-19: Mechanisms, clinical features, and implications for care
    MahendraK Garg, Maya Gopalakrishnan, Prakrati Yadav, Sanjeev Misra · 2020 · Indian Journal of Endocrinology and Metabolism
95. A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
    C. Funk, A. Ardakani · 2020 · Frontiers in Pharmacology
96. A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
    Asad Ali Usman, Jason J. Han, Andrew M. Acker, Salim E. Olia, Christian A. Bermudez, Brett L. Cucchiara, Mark E. Mikkelsen, Joyce Wanglee Wald, Emily J. MacKay, Wilson Y. Szeto et al. · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
97. Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection
    Donogh Maguire, Marylynne Woods, Conor Richards, Ross Dean Dolan, Jesse Wilson Veitch, Wei M. J. Sim, Olivia EH Kemmett, David C. Milton, Sophie Randall, Ly D Bui et al. · 2020 · Journal of Translational Medicine
98. Tissue-specific tolerance in fatal Covid-19
    David A. Dorward, C. Russell, I. Um et al. · 2020 · medRxiv
99. A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
    Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, Senthilkumar Natesan, Dewi Megawati, Karam Pal Singh, Izabela Michalak, Kuldeep Dhama · 2022 · Narra J
100. The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations
     Herman Goossens, Lennie P. G. Derde, Peter Horby, Marc J. M. Bonten · 2021 · The Lancet Infectious Diseases